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Background: Dementia syndromes are under-diagnosed and under-treated in primary care. Earlier recognition of
and response to dementia syndrome is likely to enhance the quality of life of people with dementia, but general
practitioners consistently report limited skills and confidence in diagnosis and management of this condition.
Changing clinical practice is difficult, and the challenge for those seeking change it is to find ways of working with
the grain of professional knowledge and practice. Assessment of educational needs in a practice has the potential
to accommodate variations in individual understanding and competence, learning preferences and skill mix.
Educational prescriptions identify questions that need to be answered in order to address a clinical problem.
This paper reports the development of an educational needs assessment tool to guide tailored educational
interventions designed to enhance early diagnosis and management of dementia in primary care, in the
Evidence Based Interventions in Dementia in the Community – Early Diagnosis trial.
Methods: A multidisciplinary team, including a lay researcher, used an iterative technology development approach
to create an educational needs assessment tool, from which educational prescriptions could be written. Workplace
learning was tailored to each practice using the educational prescription, and the method was field-tested in five
pilot practices.
Results: The educational prescriptions appeared acceptable and useful in volunteer practices. The time
commitment (no more than four hours, spread out at the practice’s discretion) appeared manageable. The pilot
group of practices prioritised diagnosis, assessment of carers’ needs, quality markers for dementia care in general
practice, and the implications of the Mental Capacity Act (2005) for their clinical practice. The content of the
educational needs assessment tool seemed to be comprehensive, in that no new topics were identified by
practices in the field trial.
Conclusions: The educational needs assessment tool took into account practitioners’ knowledge of the local health
and social care systems, reflected the complexity of the diagnostic and care processes for people with dementia,
and acknowledged the complexity of the disease process itself.
Keywords: Dementia, Educational needs assessment, Educational prescriptions, Primary care, Randomised
controlled trial* Correspondence: s.iliffe@ucl.ac.uk
Department of Primary Care & Population Health, UCL, Rowland Hill Street,
London NW3 2PF, UK
© 2012 Iliffe et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Iliffe et al. Trials 2012, 13:142 Page 2 of 12
http://www.trialsjournal.com/content/13/1/142Background
Dementia syndromes are under-diagnosed and under-
treated in primary care in all countries [1,2], with an
estimated 50% of primary care patients aged65 years of
age and over not diagnosed by their primary care physi-
cians [3]. The insidious and very variable development
and presentation of dementia syndromes make their
recognition problematic for primary care practitioners.
Earlier recognition of and response to dementia syn-
drome is likely to enhance the quality of life of patients,
in a number of ways. People with dementia have
been reported to want early disclosure of their diag-
nosis [4], and younger professionals want to be able to
provide this [5]. The benefits of making a diagnosis
include ending uncertainty about the cause of symptoms
and behaviour change, with greater understanding of
problems; giving access to appropriate support; promot-
ing positive coping strategies; facilitating planning; and
fulfilment of short-term goals [6-9]. There is also the
potential for using cholinesterase inhibitors to modify
symptoms and delay the need to seek nursing home care
in those people with dementia who have Alzheimer’s
disease. This body of evidence is reflected in new health
policies in England [10,11], Scotland [12], Northern
Ireland [13] and Wales [14].
Changing clinical practice is difficult. Whilst some
new and effective treatments are adopted quickly and
diffuse across health care systems, many do not [15]. An
earlier trial of an educational intervention in general
practice to enhance recognition of and response to de-
mentia achieved a significant improvement in diagnostic
rates but had no impact on the documentation of subse-
quent clinical management [16]. General practitioners
consistently report limited skills and confidence in diag-
nosis and management of dementia, and a minority see
this as a task only for specialists [17].
The adoption of new ways of working may depend on
the characteristics of the new approaches themselves,
and those of the professionals and patients who use
them. Diffusion science, elegantly summarised by Ber-
wick [15], has a great deal to say about these intrinsic
processes. The characteristics of innovations that favour
their uptake and diffusion through clinical practice
[18,19] are shown in Table 1.
The variability of general practice is a problem for
those seeking to change it, but may be an asset for
patients. As Miller and colleagues put it:
“Standardising care without identifying desirable
variation or unique adaptations that take advantage of
local opportunities or strengths misses an opportunity to
identify and investigate unanticipated circumstances
or locally adapted practice configurations associated
with better health care outcomes.” [20]The challenge for those seeking to change clinical
performance is to find ways of working with the grain of
professional knowledge and practice. Promoting earlier
recognition of a relatively uncommon condition with
a very variable presentation may be best achieved
by understanding the variability of practitioners’ know-
ledge, skills and attitudes in any given work unit. One
approach to capturing this level of detail is to use educa-
tional needs assessment (ENA) [21] to generate educa-
tional prescriptions [22]. ENA developed during the early
years of the evidence-based medicine movement. These
assessments were used by Sackett and Straus to mobilise
knowledge and evidence in clinical settings [23]. The
needs assessment approach derives from adult learning
theory as applied to clinical medicine [24]. Many tools
can be used to aid the process of learning evidence-
based medicine, including educational prescriptions [25].
Assessment of educational needs in a practice has the po-
tential to accommodate variations in individual understand-
ing and competence, learning preferences and skill mix.
Educational prescriptions identify questions that need to be
answered to address a clinical problem. Such tailoring of
an educational ‘intervention’ to the specific identified needs
of practitioners also draws on innovation theory (as men-
tioned above) in that the intervention itself can be modified
in such a way as to make it more likely to be adopted. Edu-
cational prescriptions are a useful tool when the need
to learn is not always followed-up because of a lack of
opportunity through pressure of work and fatigue, and
can be used in any practice setting [26,27].
This paper reports the development of an ENA tool to
guide tailored educational interventions designed to
enhance early diagnosis and management of dementia in
primary care, for the Evidence Based Interventions in
Dementia in the community – Early Diagnosis (EVIDEM-
ED) randomised controlled trial [28].
Methods
A co-design approach to the production of an ENA tool
was adopted to gain the insights and experiences of a
range of practitioners [29]. Co-design is an approach
that fits closely with the Medical Research Council’s
recommendations for developing a complex intervention
[30]. This involved an expert group of designers and an
expert panel of ‘critical friends’ working in an iterative
technology development process [31] to develop a proto-
type ENA tool for dementia diagnosis and management.
The prototype was refined and subsequently field-tested
with volunteer practices. The development process is
summarised in Figure 1.
The expert group
The multidisciplinary expert group was made up of
three general practitioners (GPs), an old-age psychiatrist,
Table 1 Attributes of an innovation that may determine
its uptake
Compatibility: Innovations that are compatible with the values,
norms and perceived needs of intended
adopters will be more easily adopted and
implemented.
Complexity/
ease of use:
Innovations that are perceived by key players
as simple to use will be more easily adopted
and implemented. The perceived complexity
of an innovation can be reduced by practical
experience and demonstration. (The degree to
which the innovation is expected to be free of
effort.)
Relative advantage: Innovations that have a clear, unambiguous
advantage in terms of either effectiveness or
cost-effectiveness will be more easily adopted
and implemented. This advantage must be
recognized and acknowledged by all key players.
If a potential user sees no relative advantage in
the innovation he or she does not generally
consider it further: in other words, relative
advantage is a sine qua non for adoption.
Relative advantage is a socially constructed
phenomenon: in other words, even so-called
evidence-based innovations go through a
lengthy period of negotiation amongst potential
adopters, in which their meaning is discussed,
contested and reframed; such discourse can
either increase or decrease the perceived
relative advantage of the innovation.
Trialability: Innovations that can be experimented with
by intended users on a limited basis will be
more easily adopted and implemented. Such
experimentation can be supported and
encouraged through provision of ‘trialability
space’.
Observability/result
demonstrability:
If the benefits of an innovation are visible to
intended adopters, it will be more easily
adopted and implemented. Initiatives to make
the benefits of an innovation more visible (for
example, through demonstrations) increase the
chances of successful adoption.
Reinvention: If a potential adopter can adapt, refine or
otherwise modify the innovation to suit his or
her needs, it will be more easily adopted and
implemented. Reinvention is a particularly
critical attribute for innovations that arise
spontaneously as ‘good ideas in practice’
and which spread primarily through informal,
decentralised, horizontal social networks.
Image: An innovation is more likely to be taken up if it
is seen as adding to the user's social approval.
Visibility: The degree to which the innovation is seen to
be used by others will affect its uptake.
Voluntariness: The degree to which use of the innovation is
controlled by the potential user's free will affects
the uptake of the innovation.
Expert group develops care 
path, task matrix and 
questions for Educational 
Needs Assessment
Expert Panel critiques Expert Group work and 
suggest changes to all components
Research team synthesises Expert Group and 
Panel opinion and creates prototype 
Educational Needs Assessment
Field test in five volunteer group practices
Research team identifies 
characteristics of 
successful innovation
Research team 
formulates tasks for 
expert group
Figure 1 The process of development of the educational needs
assessment tool.
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research team. The members of the expert group were
chosen on the basis of their expertise or experience
in dementia care, in professional education, or in both.
The aim of the expert group was to decide which
skills and attributes were essential for a primary careteam to have in order to deliver effective care for
patients with dementia.
The expert group was given three objectives: to design
a care pathway that would assist practitioners in earlier
diagnosis and enhance subsequent clinical management
(the care pathway); to identify the attributes a practice
would need to implement the care pathway (the task
matrix); and to use the task matrix to derive a set of
questions that would identify the practice’s learning
needs (the ENA).
One member of the expert group identified and sum-
marised literature on factors determining the uptake of
innovation [18,19]; this briefing, which included the
attributes shown in Table 1, was circulated to the whole
group before its first meeting. The expert group was also
asked to frame its work in terms of adult learning
approaches; in other words, that learning would be
problem-solving, case-based and usable by practitioners
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expert [32,33].
A modified nominal group technique was used with
the expert group to develop the prototype ENA tool.
Nominal groups are potentially powerful learning and
development tools [34]. They have a particularly useful
role in analysing health care problems [35], and can help
bridge the gap between researchers and practitioners
[36]. A nominal group approach designed for ill-
structured problems was chosen, to allow for dis-
agreements over problem definition, and for potential
solutions that overlapped or varied widely in specificity.
This required the groups to generate ideas, confirm that
they were addressing the same problem, analyse the con-
tent of the ideas, categorise ideas and clarify the items in
each category [37].
The expert group met initially to decide what the ele-
ments of a training programme designed to change prac-
tice in dementia should be. This meant identifying
what tasks needed performing to identify patients with
dementia, and to care for them appropriately in the pri-
mary care setting. The expert group designed a flow-
chart outlining the pathway that a clinician might follow
once they suspect a patient has dementia. From this, the
expert group developed questions which would identify
the practice’s strengths and weaknesses in the care of
patients with dementia.
This cyclical process of adapting and refining ideas
took place over one calendar year, and necessitated four
meetings of the expert group. The prototype ENA was
sent to the expert panel after the fourth meeting of the
expert group.
The expert panel
The expert panel comprised a group of external, inde-
pendent people who had registered their interest in the
EVIDEM project by subscribing to a mailing list on the
website, and who were then contacted by the EVIDEM
team with an invitation to contribute to the develop-
ment process. The expert panel had 13 members (of
whom one dropped out in the course of the develop-
ment process), with a mix of carers, patients and profes-
sionals, including two GPs, a social worker, a practice
nurse (PN) and an Admiral nurse.
Expert panel members were blinded to each other as
well as to the expert group members. They received and
sent comments on all the documents by email or post.
The purpose of the panel was to review the proposals
made by the expert group, to ensure that no themes
were omitted, and to decide how comprehensive, valid
and feasible the ENA was as a tool. They were also
charged with assessing whether the development of the
prototype concurred with known factors favouring the
adoption of an innovation, using literature that had beencirculated to them in advance. When this had been com-
pleted, the expert panel returned their comments and
suggestions to the expert group for review.
Field-testing process
This ENA template was then field-tested in volunteer
general practices. The practices were based in North
West and North East London, and were recruited
directly by the EVIDEM programme as part of a rando-
mised controlled trial of an educational intervention.
Practices were informed about the process and asked to
choose either field-test status or randomised controlled
trial participation. The first five respondents wanting to
join the field test were enrolled.
Two members of the research team held a group
meeting at each practice, to carry out an ENA. One team
member, experienced in group-based learning in general
practice (the expert tutor), facilitated discussion of the
questions in the needs assessment tool. The other acted
as a participant observer, ensuring that all questions
were asked and clarifying points where necessary, as well
as taking notes about the assessment process. The prac-
tices were asked to invite whichever members of staff
they thought should participate, including attached staff
from community services. The times of meetings were
left to the practice to choose. The research project paid
for lunch when lunchtime meetings were preferred.
An educational prescription was agreed at the end of
each needs assessment process, and up to three follow-
up visits were arranged to work through the themes
identified for the educational prescription. The educa-
tional prescriptions were used to collect and collate
learning materials for each practice, and the subsequent
workshops were also used to revisit and revise the ques-
tions in the ENA. Workshops were led by the expert
tutor who had facilitated the ENA process, again with a
participant observer from the research team.
Results
Table 2 shows the task matrix developed by the expert
group and modified by the expert panel, and Figure 2
shows the process of recognition and response to
dementiax syndrome in primary care, as created by the
design process.
Responses from the expert panel were positive but di-
vergent. Some panel members found the care pathway
too simple and suggested additions to make it more
comprehensive; one GP suggested an alternative version.
Responses for the tasks matrix were very practical and
the panel members filled the gaps by adding examples
on ways of achieving the targets. Many members high-
lighted that the tasks may be difficult to achieve because
of limited time during consultations and insufficient
resources. The members felt that discussion of legal
Table 2 Changing clinical practice in dementia: elements of a training programme for primary care teams
The task Objectives within the task How to achieve the objectives
Pattern recognition (interpreting the
meaning of accumulating symptoms)
Growing personal awareness/knowledge
of members of the public as well as
professional experience amongst
practitioners
- Personal experiences offer a lot of lessons.
The professional who is also a carer/relative/
friend can ‘see the other side’.
- Produce a video for professionals about the
life of people with dementia at home.
Understanding the difficulties of the
diagnostic process
- Recognition of complexity/uncertainty.
- Listening to carers and family members.
A raised profile for dementia in the GP’s
work environment (increasing
receptiveness)
- The professional and organisational culture
of the practice is important: create a learning
environment.
- Include reminders and templates in electronic
medical records.
- Seek greater understanding of cognitive
symptoms and their effects on
patients.
- Education should be tailored to individual
practice team’s needs.
Practice team awareness of the issues - Partners need to allow and encourage nurses
and receptionists to attend training. Doctors
also need to be prepared to learn from
non-medical professionals.
- Non-clinical staff need to be empowered to
alert clinicians to changes in individuals’
behaviour (for example, repeated requests for
regular medication, repeated defaults from
consultations).
- Involve the whole team in clinical meetings.
Practice systems for intelligence gathering,
collation of information and knowledge of
individual’s family circumstances and social
networks, and responsibility for acting on
that gathered knowledge
- ‘Key worker’ roles in bigger practices.
- Having ‘at risk’ registers.
- In smaller practices, all team members meet with
the patient and carer at some point of time.
- Named family or carer main contact important,
especially for those living alone.
- Establishing relationships with patient’s
neighbours/milkman and so on.
Continuity of care for individuals, which
deepens knowledge, allows observation
over time, and permits trust to develop
- Systems for maintaining continuity of care
need to be discussed explicitly, especially in
large group practices.
- Dementia needs active management by the
practice.
Managing expectations of patients and
carers by primary care team
- Promote their role in early diagnosis by explain
their roles in a simple language.
- Promote a message for those attending for
a first consultation that they will be taken
seriously and their needs listened to.
- Promote understanding that presenting for
this initial consultation may be a hard decision
for individuals/families and that ‘we’ are there
to promote the interests and care to all parties
caught up in this process.
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Table 2 Changing clinical practice in dementia: elements of a training programme for primary care teams (Continued)
Assessing the degree of impairment Getting all sides of the story: patient,
carer, others (including own team and
local Social Services in case known
to them)
- Experience matters here, so exchanging
experience may be a mechanism.
- If known to allied health
professionals, they can provide useful insights.
- Role of key worker is important as it may be
difficult to collate information from many people.
-Visit at home and seeing patients in typical
environment with typical others.
Assess the risks and challenges - Think about the level of concern of patients/
carers and others.
- What is patient like when out of ‘normal’
environment, for example, on holiday, in
hospital – provides insight into level of
impairment.
Consider other long-term conditions and
their relationship to the symptoms of
dementia, and other functional abilities
(hearing or visual impairments, mobility
problems)
- Information and explanation crucial but, with
many people, having an information cascade
is useful.
Using locally preferred (standardised)
assessment tools; knowing their limits
- There is guidance on the usefulness of the
different tools [38]
- Agreement between psychiatrists about what
they use and then pass information to GPs.
Using tacit knowledge (instincts, hunches,
acquired experience)
- Acknowledge that tacit knowledge is useful.
Self-awareness of changes in thinking
abilities (planning, calculating), and
recognition of compensatory adaptations
by other people (for example, someone
else takes over the bill-paying)
- Ask about the methods they are using to cope
with their disabilities.
Discussing possible diagnoses Disclosure – who, when and to whom?
(This is no different from breaking bad
news for any other
condition)
- Attention to context when giving diagnosis:
where it should be done, who is present, how
will they get home/be spending the rest of the
day. Involving/initiating their support network
can greatly help future management. Examples:
(1) A support package should be given with
names and addresses of the various bodies
that may be able to provide help.(2) A follow-up
visit should be arranged with a support nurse
in a week or two to enable questions to be
asked when patients and their families have
had time to think things through.
- Consider patient’s confidentiality. Think about
when you should regard the patient as being
a dependant, as in the case of a dependent child.
- A process for communications between
specialists is required to take the responsibility
of follow-up after disclosure.
Negotiate disclosure of the diagnosis
with patient/carer
- This could be tied up with end of care and
advance care planning - breaking bad news and
discussing options for the future.
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Table 2 Changing clinical practice in dementia: elements of a training programme for primary care teams (Continued)
Responding Maintain a positive attitude about
dementia: ‘something can be done’ -
based on awareness of local resources
- Wider understanding about differential diagnosis
(Alzheimer’s disease/vascular dementia/Lewy body
dementia) and its implications for treatment and
management.
- Awareness of range of possible interventions
other than medical treatment. For example:
training packages for improving communication
and use of activities such as Sonas).
- Forming closer links between GP surgeries and
local dementia specialist support services.
Getting support and involvement of
secondary care
- Specialist services offer assessment and diagnostic
services. Having a responsive local specialist service
makes a difference to GP behaviour.
- May be useful if special services could provide a
summary of how their cognitive symptoms
translate into activities of daily living and some
strategies of dealing with them.
- Lack of accessibility and approachability of the
resources could lead GPs to feel unsupported and
frustrated. Training of psycho-geriatricians and
improved communication could help.
Phase in responses involving resources/
services
- Professional requires clear understanding of what
is available.
- Requires an assessment of that person’s needs,
and those of their family or other supporters.
Locate services and assess if they make
a difference
- Think in terms of advanced support systems,
care packages, alarm systems, simple behavioural
strategies for carers.
- Map local and national services, including
voluntary organisations.
Medication for dementia and ‘shared
care’ systems
-T ake cultural factors of the practice and local
specialist services into consideration.
Support for carers (practical, information,
psychological support ) means understanding
how and why family members respond
differently to dementia
- Liaise with local carers’ group.For example,
names and addresses of other patients at a
similar stage of the illness made available
(if there is consent) for perhaps a ‘buddy’ system.
- Be aware that stigma applies to services as well
as dementia itself. This may influence your
source of advice.
- Assess capacity and effect of the new Act/
importance of discussing power of attorney early
on while the patient still has capacity.
- Record patient’s views early on in the disease
process so that can use this as a guide later.
GP: general practitioner.
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importance and should be accomplished at early stages.
The two GPs on the expert panel commented on the
ENA prototype, warning against taking an over-
simplistic approach and interpreting responses too nar-
rowly. They further thought that the lack of time and
the unknown effectiveness of the intervention might dis-
courage general practices from participating in the edu-
cational trial.
The educational needs assessment tool
After incorporation of the feedback from the expert
panel, a prototype version of the needs assessment tool
suitable for field-testing was prepared. This is shown in
Table 3, which outlines the questions that are asked of
the practice, and what the aims of asking those questionsare. The third column contains notes for the facilitator
carrying out the assessment, reminding them of points
to bring up or approaches to take.
The list of questions asked of the GP practice was
designed to elicit information about what systems were
already in place for the diagnosis of and care for patients
with dementia. The questions were also designed to en-
courage all staff to reflect on what they were already
doing, whether they were doing that well, and what they
needed to change in order to fill gaps in knowledge and
provision of care.
Field testing
Each of the five volunteer practices in the field test was
visited to outline the process and obtain informed con-
sent. For each volunteer practice, at the subsequent
Problem
Are there symptoms 
syndrome?
Record events and
arrange review
Consider alternative 
depression
Discussion of possible diagnoses with patient and /or 
carer
Yes
Is there cognitive impairment?
No
Yes
No
Phasing in support through general
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Consider psychosocial and
taking informant history
Develop strategy to
monitor events (esp. 
for people who do
not approach social
services)
Go through practical Referral to support services 
Nurses for patients & carers
Refer for specialist assessment, 
scan) & support 
Results based on
informant history
Discuss specific anti-
medication
Liaise with voluntary 
organisations and provide them
with patient information
Develop shared care 
protocol of medication
Address issues of carer
needs and systematic follow 
up. Who does it? Ho
suggestive of dementiadiagnosis e.g. 
practice and information sharing
biological risk factors by
aspects of living
with dementia e.g.
legal, DVLA, wills 
e.g. Social work and care/
Befriending /voluntary
service support/ Admiral 
formal diagnosis (including CT
blood tests, 
cognitive tests and
dementia 
medication and
review use of other 
+
Figure 2 A process of recognition and response in dementia.
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to a summary of the discussion and returned to the
practices. A dummy example of the combined ENA and
educational prescription is shown below. Subsequentworkshops were arranged at the ENA visit, usually with
a gap of two to four weeks between them. The research
team assembled material in written and electronic form
for each of the items on the educational prescription.
Table 3 Educational needs assessment for dementia care in general practice
QUESTION WHAT THE ANSWERS TELL US WHAT WE DO
1. How would you rate your current
care for people with dementia and their
carers (using a simple scale of good
enough/satisfactory/needs substantial
improvement)?
Answers will indicate whether focused
educational input is needed or broader
input (this is a very subjective assessment -
the practice may be better or worse than
it thinks).
Gives the research team some sense of scale
of need and time commitment, and may
permit preliminary selection of learning
materials and resources.
2. What grounds or criteria is your rating
based on?
Identifies more clearly the areas of strength
and weakness, from practice perspective,
for example, is the major problem with
diagnosis, or disclosure of the diagnosis,
or judging impairment, or knowing what
the appropriate responses and resources are?
Sense of priorities for learning will begin to
emerge here.
3. Does the number of people in your
practice diagnosed with dementia
correlate with the local prevalence figures?
Reflects local demography and under-
recognition.
GPs tend to overestimate prevalence and
likely future workload, so some reframing
possible (we need epidemiological data).
4. How do you arrive at your decision for
diagnosis of dementia?
Tells us about the diagnostic procedure
followed in the practice. It will also inform
us on who makes the diagnosis.
Helps identify roles within the practice team.
Skill mix and experiences within the group
can then be shared between colleagues with
the opportunity for peer to peer learning.
5. How many older people with suspected
dementia did you refer last year?
Reveals the practice culture (transfer of
responsibility to specialist services versus
GP care).
We will know if we need to increase their
capacity to provide GP care or simply reinforce
existing good practice.
6. After diagnosis, what follow-up do you
provide to people with dementia and their
carers?
Opens up discussion about systematisation
of care within the practice and resources
available to the practice.
Provides knowledge on their case management
methods as well as a local (and national)
directory of resources.
7. Are you using a shared care protocol
for cholinesterase inhibitors? If ‘yes’, then:
(i) who was involved in producing the
protocol; (ii) who is involved in its
implementation (for example, hospital
consultants, community psychiatric nurses,
care of older people team)
Awareness of protocol (if it exists), and its
appropriateness for general practice.
Rehearse use of (GP-developed) shared care
protocol.
8. How effective do you think
cholinesterase inhibitors are and how
effective have you found them in your
practice?
Awareness of realistic likely impact of
cholinesterase inhibitors.
Discussion of trial data on cholinergic drug
effects.
9. What non-pharmacological alternatives
do you have available to help your patients
(and their carers)?
Will indicate extent of networking with local
services as well as identify practice resources
usable by people with dementia.
Provision of information about cognitive
reframing and other psychosocial support
methods.
10. Based on your experience, what do
you think are the important quality markers
in caring for people with dementia?
(What would you want for yourself?)
Elicits both clinical and personal experience;
may provide very useful case vignettes.
Fit the practice’s conception of quality markers
to the NICE/SCIE guideline indicators [40].
11. Is there anything that you would like
improve? If yes, what is it and why would
you like it to change?
Prioritisation of learning needs. Highly focused educational input.
GP: general practitioner; NICE: National Institute for Health and Clinical Excellence; SCIE: Social Care Institute for Excellence.
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prescription
A group practice in locality X, with young GPs, working
from a spacious once-commercial building. Four GPs
and four PNs took part in the workshop. They described
their care for people with dementia as somewhere be-
tween ‘satisfactory’ and ‘needs substantial attention’, and
reactive rather than proactive. They seemed uncertain
how to describe or define ‘good care’ for people with de-
mentia, ‘We are confused and are not sure if what we
are doing is right’. They compared their care for people
with dementia with the services they provide for theirpatients with diabetes. Approximately 600 of their
patients were diabetic and they diagnose one new pa-
tient per week. All those patients get seen and they have
a 6-monthly follow-up system with them. It is not the
same for dementia and they felt the need to bring de-
mentia forward in their priorities. They estimated that
they had 17 people with dementia on their register and
that there were another 14 unrecognised.
When discussing the diagnostic process, a PN talked
about a patient of hers who needed regular anticoagu-
lant monitoring, and who was forgetting to keep her
appointments for measurement of her international
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been bereaved about 18 months ago, but did not think
there was anything wrong with her. Her daughter lived
with her during the week. The PN now made a habit of
calling this patient to remind her about tests and pre-
scriptions, and had tried to contact the daughter to see
if she thought anything was wrong, but had not suc-
ceeded in speaking with her.
A doctor added her own perspective on this sort of
situation; she did not know if a patient’s failure to under-
stand medical advice or instructions was due to her
being too complicated in her explanations, or the patient
not being unable to understand simple things. Another
doctor raised concern about the issue of confidentiality.
He gave an example of a patient whose daughter called
because she was concerned about her mother being for-
getful, but did not want her mother to know that she
had called. He was not sure what he could do without
seeing the patient and referred the daughter to the local
Alzheimer’s society branch. He was also concerned
about how to tell the difference between dementia and
general forgetfulness.
A third doctor mentioned ‘mutual collusion’ in the
early stages of dementia, ‘When you are aware there is a
problem and the patients know there is a problem’ but
there is an uncertainty about diagnosis. She has had
patients who admit having memory problems but have
high mini-mental state examination scores. ‘Does that
mean they don’t have dementia?’
Question 5 (How many older people with suspected
dementia did you refer last year?) seems redundant for
this group.
There was some confusion about shared care policies
and care pathways for dementia, but this was due in part
to the geographical position of the practice on the
boundary of three primary care trusts (PCTs). The prac-
tice has patients from two adjacent PCTs. PCT1 is pro-
active in using a shared care protocol. PCT 2 does not
have any fixed protocol but there are guidelines to be
followed which are very unclear and they are not using
them. They received a dementia care pathway from the
PCT but have not started using it. Care seemed to be
transferred to specialist services, without much aware-
ness of what those services actually did, “The majority of
our patients get referred to the specialist and they are
very well taken care of”.
Their emphasis was on improving their diagnostic
skills, and there was no discussion of how to manage be-
havioural and psychological problems. They were aware
of the local Alzheimer society branch’s services, and had
a sense that carers were left unsupported after the early
encounters with the community mental health team.
They felt that patients with dementia types other than
Alzheimer’s disease were easily ‘lost’.They were not impressed by the effectiveness of
cholinesterase inhibitors, but did not prescribe many.
They did not think they had access to any forms of
psychosocial support or care for people with dementia.
They decided on four quality indicators for the prac-
tices dementia care: 1. offering referral when the diagno-
sis was suspected; 2. supportive towards carers; 3. carer
satisfaction with their support; and 4. 6-monthly review
of all people with dementia.
The prescription for education that we agreed upon was:
1. to focus on the diagnostic process in complex cases;
2. to design a systematic way of reviewing and
supporting people with dementia and carers, guided
by quality markers;
3. to develop a closer working relationship with the
community mental health team and have a clearer
view of the services available;
4. to improve their knowledge of legal issues in
dementia, especially of the Mental Capacity
Act 2005.
Table 4 shows the characteristics of the practices in
the field test, the participation of different disciplines,
the number of workshops held with each practice, and
the themes identified in their ‘educational prescription’.
As a result of the field-testing, the variety of learning
materials used was broadened to include more reference
material for use during sessions. The timing planned for
topics was also amended and the expert tutors became
more knowledgeable and aware of areas of need that
were consistent across individuals and groups.
Discussion
The educational prescriptions developed through ENA
appeared acceptable and useful in volunteer practices.
The time commitment (no more than four hours, spread
out at the practice’s discretion) appeared manageable.
The pilot group of practices prioritised diagnosis, assess-
ment of carers’ needs, quality markers for dementia care
in general practice, and the implications of the Mental
Capacity Act (2005) for their clinical practice. The con-
tent of the ENA seemed to be comprehensive, in that no
new topics were identified by practices in the field trial.
On the basis of this pilot the ENA tool was used in the
full EVIDEM-ED randomised controlled trial, and its
effectiveness will be reported at the end of the trial,
in autumn 2012.
The ENA tool developed here is an example of a
quality improvement intervention, a strategy aimed at
improving quality of care by overcoming the translation
block that prevents clinical guidelines and knowledge
being put into practice [39]. The methods used to
develop the ENA are consistent with the advice given
Table 4 Practice information, educational needs assessment attendance and themes identified for educational
prescriptions
Practice Inner city,
GP led
Outer city,
GP led
Outer city,
nurse-led
Outer city, GP-led
training practice
Inner city,
GP led
List size 6,300 9,100 6,000 5,200 10,500
Non-clinical staff present? ✓ - ✓ - -
Community staff present? - - ✓ - -
Diagnostic methods ✓ ✓ ✓ ✓ ✓
Shared care protocol ✓ - ✓ - ✓
Behavioural and psychological symptoms
of dementia management
✓ - ✓ ✓ -
Carers needs and quality markers ✓ ✓ ✓ ✓ ✓
Mental Capacity Act 2005 and legal issues ✓ ✓ ✓ ✓ -
Complex case discussion ✓ ✓ - - -
Improved service awareness and
collaboration
- ✓ ✓ - ✓
Care planning - - ✓ ✓ ✓
GP: general practitioner.
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experts is effective in changing practice, and multifaceted
interventions targeting specific barriers to change are
more effective than single interventions [40].
The effectiveness of this intervention is being tested in
a cluster randomised controlled trial, which is its defini-
tive test. The intervention has been developed in ways
consistent with current understanding of how effective
interventions are derived. Nevertheless, there may have
been deficiencies in the development process. For
example, the views of people with dementia and their
family carers may not have had sufficient weight. Some
professional perspectives may have been too powerful;
the absence of response from expert panel members to
the ENA questions themselves could be a sign of this.
The expert group may not have used the critical com-
ments made by the expert panel sufficiently, resulting in
an over-simplification of the ENA. The volunteer prac-
tices are probably different from others, in that they
wanted to take part in a pilot educational programme
about dementia. Finally, the expert tutor may have had
an effect on the use of the ENA and the ‘filling’ of the
educational prescription, even though we used a partici-
pant observer to avoid idiosyncratic interpretations of
the group discussions.
Conclusions
The ENA took into account practitioners’ knowledge of
the local health and social care systems, reflected the
complexity of the diagnostic and care processes for
people with dementia, and acknowledged the complexity
of the disease process itself [41]. It balanced participation
(the engagement with practices as working groups) with
expertise (the evidence-based knowledge introduced intothe practice) to ‘fill’ its educational prescription [42].
The ENA and educational prescription addressed each
practice’s orientation to the clinical problem, its insight
into its own performance, and its acceptance of the need
to make specific changes or acquire new knowledge or
skills [42]. Finally, the ENA and subsequent intervention
have features of the kind of reflective adaptive process
that allows local strategies for development to emerge.
These features include creating time and space to plan
changes, tolerating tension and discomfort as normal
and useful in initiating change, and the inclusion of a
variety of system members [43]. We will return to these
issues when we report on the implementation of the
ENA in the definitive trial.
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